Peptinov SAS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.peptinov.fr
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)PPV-06 Vaccine in Inflammatory Knee Osteoarthritis
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-09-20
- Lead Sponsor
- Peptinov SAS
- Target Recruit Count
- 204
- Registration Number
- NCT06605963
- Locations
- 🇫🇷
CIC Cochin, Paris, France
Dose Escalation Study Assessing the Safety and Immune Response of PPV-06 Vaccine
Phase 1
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: PPV-06 10 μgDrug: PPV-06 50 μgDrug: Placebo
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Peptinov SAS
- Target Recruit Count
- 24
- Registration Number
- NCT04447898
- Locations
- 🇫🇷
Cic Cochin, Paris, France
News
No news found